^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
MIL93
i
Other names: MIL93, recombinant humanized anti-Claudin 18.2 mab
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Beijing Mabworks Biotech
Drug class:
CLDN18.2 inhibitor
Related drugs:
Phase 1
Beijing Mabworks Biotech Co., Ltd.
Recruiting
Last update posted :
03/13/2024
Initiation :
04/21/2021
Primary completion :
08/01/2025
Completion :
08/01/2025
CLDN18
|
CLDN18.2 positive
|
MIL93
Share
